Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The sigma non-opioid intracellular receptor 2, or sigma‑2 receptor, is now recognized as TMEM97—a transmembrane EXPERA domain protein primarily located at the endoplasmic reticulum membrane. It plays roles distinct from those of its better-characterized counterpart, SIGMAR1/sigma‑1. Its elevated expression in cancer cells makes it an active area of research both as a therapeutic target and diagnostic marker.
Small-molecule modulators interact with this receptor for diagnostic and therapeutic purposes
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sigma Non-Opioid Intracellular Receptor 2 (Sigma-2 Receptor).